Literature DB >> 24917741

A prospective study of the role of inflammation in bladder cancer.

Tahir Qayyum1, Peter McArdle2, Mustafa Hilmy2, James Going3, Clare Orange4, Morag Seywright4, Paul Horgan5, Mark Underwood2, Joanne Edwards1.   

Abstract

INTRODUCTION: To examine the role of inflammation in bladder cancer, we assessed the relationship between a systemic inflammation prognostic score (modified Glasgow Prognostic Score, mGPS), the tumor inflammatory cell infiltrate as measured by the Klintrup-Makinen score and tumor necrosis with cancer specific survival in patients with bladder cancer.
MATERIALS AND METHODS: The cohort consisted of 68 bladder cancer patients, 47 with localised disease and 21 with muscle invasive disease. The mGPS response was constructed by measuring C-reactive protein and albumin concentrations and the Klintrup-Makinen score was evaluated histologically for the local inflammatory response. Pathological parameters such as grade, T stage and tumor necrosis were also assessed.
RESULTS: Median follow was 47 months and 24 patients died of their disease. On univariate analysis, T stage (p < 0.001), grade (p < 0.001) and mGPS (p = 0.002) were significant predictors of cancer specific survival. On multivariate analysis, T stage (hazard ratio 5.98, 95% confidence interval 3.18-11.24, p < 0.001) and mGPS (hazard ratio 1.78, 95% confidence interval 1.09-2.9, p = 0.02) were significant independent predictors of cancer specific survival.
CONCLUSION: A preoperative systemic inflammatory response is an independent predictor of poor cancer specific survival in patients with bladder cancer.

Entities:  

Keywords:  Bladder cancer; C-reactive protein; Glasgow prognostic score; Inflammation; Klintrup-Makinen score

Year:  2013        PMID: 24917741      PMCID: PMC3783284          DOI: 10.1159/000343537

Source DB:  PubMed          Journal:  Curr Urol        ISSN: 1661-7649


  26 in total

Review 1.  The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.

Authors:  J I Epstein; M B Amin; V R Reuter; F K Mostofi
Journal:  Am J Surg Pathol       Date:  1998-12       Impact factor: 6.394

2.  Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue.

Authors:  H J Nielsen; U Hansen; I J Christensen; C M Reimert; N Brünner; F Moesgaard
Journal:  J Pathol       Date:  1999-12       Impact factor: 7.996

3.  Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer.

Authors:  Donald C McMillan; Joseph E M Crozier; Khalid Canna; Wilson J Angerson; Colin S McArdle
Journal:  Int J Colorectal Dis       Date:  2007-01-24       Impact factor: 2.571

4.  Systemic inflammatory response and survival in patients with localised prostate cancer: 10-year follow-up.

Authors:  Peter A McArdle; Tahir Qayyum; Donald C McMillan
Journal:  Urol Int       Date:  2010-04-15       Impact factor: 2.089

5.  Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness.

Authors:  Shomik Sengupta; Christine M Lohse; Bradley C Leibovich; Igor Frank; R Houston Thompson; W Scott Webster; Horst Zincke; Michael L Blute; John C Cheville; Eugene D Kwon
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

6.  Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score.

Authors:  Georgios Gakis; Tilman Todenhöfer; Markus Renninger; David Schilling; Karl-Dietrich Sievert; Christian Schwentner; Arnulf Stenzl
Journal:  BJU Int       Date:  2011-04-20       Impact factor: 5.588

7.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

Review 8.  Inflammation and cancer.

Authors:  Lisa M Coussens; Zena Werb
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

9.  The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder.

Authors:  M Hilmy; J M S Bartlett; M A Underwood; D C McMillan
Journal:  Br J Cancer       Date:  2005-02-28       Impact factor: 7.640

10.  Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer.

Authors:  A B C Crumley; D C McMillan; M McKernan; A C McDonald; R C Stuart
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more
  10 in total

1.  Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer.

Authors:  Laura von der Emde; Diane Goltz; Stefan Latz; Stefan C Müller; Glen Kristiansen; Jörg Ellinger; Isabella Syring
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

2.  Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.

Authors:  Feng Qi; Yunqiu Xu; Yuxiao Zheng; Xiao Li; Yang Gao
Journal:  Ann Transl Med       Date:  2019-10

3.  Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma.

Authors:  Bo Zhang; Wei Yu; Li-Qun Zhou; Zhi-Song He; Cheng Shen; Qun He; Jun Li; Li-Bo Liu; Cong Wang; Xiao-Yu Chen; Yu Fan; Shuai Hu; Lei Zhang; Wen-Ke Han; Jie Jin
Journal:  PLoS One       Date:  2015-12-17       Impact factor: 3.240

4.  Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro.

Authors:  Jennifer Bourn; Maria Cekanova
Journal:  Drug Des Devel Ther       Date:  2018-06-13       Impact factor: 4.162

Review 5.  Role of Systemic Inflammatory Response Markers in Urothelial Carcinoma.

Authors:  Hyeong Dong Yuk; Ja Hyeon Ku
Journal:  Front Oncol       Date:  2020-08-21       Impact factor: 5.738

6.  Detection of carcinogen-induced bladder cancer by fluorocoxib A.

Authors:  Jennifer Bourn; Kusum Rathore; Robert Donnell; Wesley White; Md Jashim Uddin; Lawrence Marnett; Maria Cekanova
Journal:  BMC Cancer       Date:  2019-11-27       Impact factor: 4.430

7.  Preoperative Plasma Fibrinogen Level Represents an Independent Prognostic Factor in a Chinese Cohort of Patients with Upper Tract Urothelial Carcinoma.

Authors:  Bo Zhang; Yi Song; Jie Jin; Li-Qun Zhou; Zhi-Song He; Cheng Shen; Qun He; Jun Li; Li-Bo Liu; Cong Wang; Xiao-Yu Chen; Yu Fan; Shuai Hu; Lei Zhang; Wei Yu; Wen-Ke Han
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

8.  Detection of tyrosine kinase inhibitors-induced COX-2 expression in bladder cancer by fluorocoxib A.

Authors:  Jennifer Bourn; Sony Pandey; Jashim Uddin; Lawrence Marnett; Maria Cekanova
Journal:  Oncotarget       Date:  2019-08-27

9.  Modified Glasgow Prognostic Score as a Predictor of Recurrence in Patients with High Grade Non-Muscle Invasive Bladder Cancer Undergoing Intravesical Bacillus Calmette-Guerin Immunotherapy.

Authors:  Matteo Ferro; Octavian Sabin Tătaru; Gennaro Musi; Giuseppe Lucarelli; Abdal Rahman Abu Farhan; Francesco Cantiello; Rocco Damiano; Rodolfo Hurle; Roberto Contieri; Gian Maria Busetto; Giuseppe Carrieri; Luigi Cormio; Francesco Del Giudice; Alessandro Sciarra; Sisto Perdonà; Marco Borghesi; Carlo Terrone; Evelina La Civita; Pierluigi Bove; Riccardo Autorino; Matteo Muto; Nicolae Crisan; Michele Marchioni; Luigi Schips; Francesco Soria; Daniela Terracciano; Rocco Papalia; Felice Crocetto; Biagio Barone; Giorgio Ivan Russo; Stefano Luzzago; Giuseppe Mario Ludovico; Mihai Dorin Vartolomei; Francesco Alessandro Mistretta; Vincenzo Mirone; Ottavio de Cobelli
Journal:  Diagnostics (Basel)       Date:  2022-02-25

10.  Modified Glasgow Prognostic Score is Associated With Risk of Recurrence in Bladder Cancer Patients After Radical Cystectomy: A Multicenter Experience.

Authors:  Matteo Ferro; Ottavio De Cobelli; Carlo Buonerba; Giuseppe Di Lorenzo; Marco Capece; Dario Bruzzese; Riccardo Autorino; Danilo Bottero; Antonio Cioffi; Deliu Victor Matei; Michele Caraglia; Marco Borghesi; Ettore De Berardinis; Gian Maria Busetto; Riccardo Giovannone; Giuseppe Lucarelli; Pasquale Ditonno; Sisto Perdonà; Pierluigi Bove; Luigi Castaldo; Rodolfo Hurle; Gennaro Musi; Antonio Brescia; Michele Olivieri; Amelia Cimmino; Vincenzo Altieri; Rocco Damiano; Francesco Cantiello; Vincenzo Serretta; Sabino De Placido; Vincenzo Mirone; Guru Sonpavde; Daniela Terracciano
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.